SCHEMBL21928626

SCHEMBL21928626

Cc1cc(C)c(-c2ccc3c(c2)c2ccccc2n3-c2cncc(-n3c4ccccc4c4cc(-c5c(C)cc(C)cc5C)ccc43)c2-c2ccc(C#N)cc2)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 2/20 0.40
CHEK1 O14757 1/20 0.35
AR P10275 2/20 0.35
RORC P51449 5/20 0.34
KDM1A O60341 3/20 0.34
KCNH2 Q12809 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34
PDE9A O76083 1/20 0.34
PDE1C Q14123 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21928625 0.95 CHEK1 (0.39) PTGER4CHEK1ARKDM1AKCNH2
SCHEMBL21929292 0.94 CHEK1 (0.38) CHEK1ARKDM1AKCNH2SCN10A
SCHEMBL21931711 0.92 PTGER4 (0.37) PTGER4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL21928448 0.91 PTGER4 (0.40) PTGER4CHEK1ARRORCKCNH2
SCHEMBL21929284 0.90 PTGER4 (0.41) PTGER4CHEK1ARRORCKDM1A
SCHEMBL21931741 0.90 PTGER4 (0.40) PTGER4CHEK1ARRORCKDM1A
SCHEMBL21931737 0.90 PTGER4 (0.40) PTGER4CHEK1ARRORCKDM1A
SCHEMBL25659019 0.90 PTGER4 (0.40) PTGER4CHEK1ARRORCPDE9A
SCHEMBL21928615 0.90 PTGER4 (0.38) PTGER4CHEK1ARRORCKDM1A
SCHEMBL24737225 0.89 CHEK1 (0.42) CHEK1ARKDM1AKCNH2SCN10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 PTGER4 1018/4885CHEK1 3808/4885AR 1616/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA PTGER4 1294/4885CHEK1 1237/4885AR 2795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.